Individual differences, immunity, and cancer: Lessons from personality psychology

Brain, Behavior, and Immunity

Volumn 17, Issue 1 SUPPL., 2003, Pages 92-97

  Segerstrom, Suzanne C ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

Author keywords

Cancer; Immunity; Interactionism; Methodology; Opt imism; Personality; Reliability; Stress

Indexed keywords

IMMUNOGLOBULIN A ANTIBODY;

CANCER; CANCER GROWTH; CANCER RESEARCH; CELL ACTIVITY; COGNITION; CONFERENCE PAPER; DELAYED HYPERSENSITIVITY; DISEASE COURSE; EMOTIONAL STRESS; HUMAN; HYPOTHESIS; IMMUNE SYSTEM; IMMUNITY; MENTAL STRESS; METHODOLOGY; MOOD; NATURAL KILLER CELL; PERSONALITY; PRIORITY JOURNAL; PSYCHOLOGY; QUALITY OF LIFE; THEORETICAL MODEL; IMMUNOLOGY; IMMUNOMODULATION; NEOPLASM; PHYSIOLOGY; PSYCHOLOGICAL ASPECT; REVIEW;

HUMANS; IMMUNITY; NEOPLASMS; NEUROIMMUNOMODULATION; PERSONALITY;

EID: 0037293038     PISSN: 08891591     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0889-1591(02)00072-7     Document Type: Conference Paper

References (48)

1. Armstrong A.C., Eaton D., Ewing J.C. Cellular immunotherapy for cancer. BMJ. 323:2001;1289-1293.
2. Ben-Eliyahu S., Shakhar G. The impact of stress, catecholamines, and the menstrual cycle on NK activity and tumor development: From in vitro studies to biological significance. Ader R., Felten D., Cohen N. Psychoneuroimmunology. 2nd ed. 2001;Academic Press, San Diego.
3. Bolger N., Schilling E.A. Personality and the problems of everyday life: The role of neuroticism in exposure and reactivity to daily stressors. J. Pers. 59:1991;355-386.
4. Bowers K.S. Situationism in psychology: An analysis and a critique. Psychol. Rev. 80:1973;307-336.
5. Butow P.N., Hiller J.E., Price M.A., Thackaway S.V., Kircker A., Tennant C.C. Epidemiological evidence for a relationship between life events, coping style, and personality factors in the development of breast cancer. J. Psychosom. Res. 49:2000;169-181.
6. + Black women at risk for cervical cancer. Psychosom. Med. 60:1998;714-722.
7. Carver C.S., Scheier M.F. On the self-regulation of behavior. 1998;Cambridge University Press, Cambridge, UK.
8. Cassileth B.R., Lusk E.J., Miller D.S., Brown L.L., Miller C. Psychosocial correlates of survival in advanced malignant disease? N. Engl. J. Med. 312:1985;1551-1555.
9. Cohen F., Kearney K.A., Zegans L.S., Kemeny M.E., Neuhaus J.M., Stites D.P. Differential immune system changes with acute and persistent stress for optimists vs. pessimists. Brain Behav. Immun. 13:1999;155-174.
10. Epstein S. The stability of behavior: I. On predicting most of the people much of the time. J. Pers. Soc. Psychol. 37:1979;1097-1126.
11. Fawzy F.I., Fawzy N.W., Hyun C.S., Elashoff R., Guthrie D., Fahey J.L., Morton D.L. Malignant melanoma: Effects of an early structured psychiatric intervention, coping, and affective state on recurrence and survival 6 years later. Arch. Gen. Psychiatr. 50:1993;681-689.
12. Fawzy F.I., Kemeny M.E., Fawzy N.W., Elashoff R., Morton D., Cousins N., Fahey J.L. A structured psychiatric intervention for cancer patients: II. Changes over time in immunological measures. Arch. Gen. Psychiatr. 47:1990;729-735.
13. Friberg S., Mattson S. On the growth rates of human malignant tumors: Implications for medical decision making. J. Surg. Oncol. 65:1997;284-297.
14. Futterman A.D., Kemeny M.E., Shapiro D., Fahey J.L. Immunological and physiological changes associated with induced positive and negative mood. Psychosom. Med. 56:1994;499-511.
15. Garssen B., Goodkin K. On the role of immunological factors as mediators between psychosocial factors and cancer progression. Psychiatry Res. 85:1999;51-61.
16. Greer S. Psychological response to cancer and survival. Psychol. Med. 21:1991;43-49.
17. Gross J. Emotional expression in cancer onset and progression. Soc. Sci. Med. 28:1989;1239-1248.
18. Headey B., Wearing A. Personality, life events, and subjective well-being: Toward a dynamic equilibrium model. J. Pers. Soc. Psychol. 57:1989;731-739.
19. Herbert T.B., Cohen S. Stress and immunity in humans: A meta-analytic review. Psychosom. Med. 55:1993;364-379.
20. Jamison R.N., Burish T.G., Wallston K.A. Psychogenic factors in predicting survival of breast cancer patients. J. Clin. Oncol. 5:1987;768-772.
21. Jamner J.D., Schwartz G.E., Leigh H. The relationship between repressive and defensive coping style and monocyte, eosinophil, and serum glucose levels: Support for the opioid peptide hypothesis of repression. Psychosom. Med. 50:1988;567-575.
22. John O.P., Srivastava S. The big five trait taxonomy: History, measurement, and theoretical perspectives. Pervin L.A., John O.P. Handbook of personality: Theory and research. 1999;102-138 Guilford, New York.
23. Kiecolt-Glaser J.K., Cacioppo J.T., Malarkey W.B., Glaser R. Acute psychological stressors and short-term immune changes: What, why, for whom, and to what extent? Psychosom. Med. 54:1992;680-685.
24. Lesourd B.M., Winters W.D., Darnell B. Antigen specific stimulation of immune responses during long-term repeated skin testing with multiple antigens. J. Clin. Lab. Immunol. 21:1986;17-22.
25. Miller G.E., Cohen S., Herbert T.B. Pathways linking major depression and immunity in ambulatory female patients. Psychosom. Med. 61:1999;850-860.
26. Miller G.E., Cohen S., Rabin B.S., Skoner D.P., Doyle W.J. Personality and tonic cardiovascular, neuroendocrine, and immune function. Brain Behav. Immun. 13:1999;109-123.
27. Mischel W. Personality and assessment. 1968;Wiley, New York.
28. Mischel W. Continuity and change in personality. Am. Psychol. 24:1969;1012-1018.
29. Mullen B., Suls J. The effectiveness of attention and rejection as coping styles: A meta-analysis of temporal differences. J. Psychosom. Res. 26:1982;43-49.
30. Pardoll D.M. Stress, NK receptors, and immune surveillance. Science. 294:2001;534-536.
31. Saudino K.J., Pedersen N.L., Lichtenstein P., McClearn G.E., Plomin R. Can personality explain genetic influences on life events? J. Pers. Soc. Psychol. 72:1997;196-206.
32. Scheier M.F., Carver C.S. Optimism, coping, and health: Assessment and implications of generalized outcome expectancies. Health Psychol. 4:1985;219-247.
33. Segerstrom S.C. Personality and the immune system: Models, methods, and mechanisms. Ann. Behav. Med. 22:2000;180-190.
34. Segerstrom S.C. Optimism and attentional bias for negative and positive stimuli. Pers. Soc. Psychol. Bull. 27:2001;1334-1343.
35. Segerstrom S.C. Optimism, goal conflict, and stressor-related immune change. J. Behav. Med. 24:2001;441-467.
36. Segerstrom, S. C., Castaneda, J. O., & Spencer, T. E. (in press). Optimism effects on cellular immunity: Testing the affective and persistence models. Pers. Ind. Diff.
37. Segerstrom S.C., Taylor S.E., Kemeny M.E., Fahey J.L. Optimism is associated with mood, coping, and immune change in response to stress. J. Pers. Soc. Psychol. 74:1998;1646-1655.
38. Sieber W.J., Rodin J., Larson L., Ortega S., Cummings N., Levy S., Whiteside T., Herberman R. Modulation of human natural killer cell activity by exposure to uncontrollable stress. Brain Behav. Immun. 6:1992;141-156.
39. Souberbielle B., Dalgleish A. Anti-tumour immune mechanisms. Lewis C.E., O'Sullivan C., Barraclough J. The psychoimmunology of cancer. 1994;Oxford University Press, Oxford.
40. Spiegel D., Kato P.M. Psychosocial influence on cancer incidence and progression. Harv. Rev. Psychiatry. 4:1996;10-26.
41. Stone A.A. Selected methodological concepts: Mediation and moderation, individual differences, aggregation strategies, and variability of replicates. Schneiderman N., McCabe P., Baum A. Perspectives in behavioral medicine: Stress and disease processes. 1992;Erlbaum, Hillsdale, NJ.
42. Stone A.A., Cox D.S., Valdimarsdottir H., Jandorf L., Neale J.M. Evidence that secretory IgA antibody is associated with daily mood. J. Pers. Soc. Psychol. 52:1987;988-993.
43. Suls J., Fletcher B. The relative efficacy of avoidant and nonavoidant coping strategies: A meta-analysis. Health Psychol. 4:1985;249-288.
44. Temoshok L. Personality, coping style, emotion, and cancer: Towards an integrative model. Cancer Surv. 6:1987;545-567.
45. Temoshok L., Heller B.W. On comparing apples, oranges, and fruit salad: A methodological overview of medical outcome studies in psychosocial oncology. Cooper C.L. Psychosocial stress and cancer. 1984;Wiley, New York.
46. Turner-Cobb J.M., Sephton S.E., Spiegel D. Psychosocial effects on immune function and disease progression in cancer: Human studies. Ader R., Felton D.L., Cohen N. Psychoneuroimmunology. 3rd ed. 2001;Academic Press, San Diego, CA.
47. Watson D., Clark L.A. Negative affectivity: The disposition to experience aversive emotional states. Psychol. Bull. 96:1984;465-490.
48. Whiteside T.L., Herberman R.B. The role of natural killer cells in immune surveillance of cancer. Curr. Opin. Immunol. 7:1995;704-710.